
NexPlasmaGen
Developer of cold plasma delivery system designed to reduce cancer recurrence. The company's patented cold plasma device generates plasma species, producing cellular oxidative stress that kills cancer...
Valuation
$0
Share Price
N/A
Total Raised
$570K
Last Round
N/A